Cottonwood Technology Fund

Cottonwood Technology Fund, established in 2009, is a venture capital firm headquartered in Santa Fe, New Mexico, with additional offices in Los Alamos, New Mexico, El Paso, Texas, and Enschede, The Netherlands. The firm specializes in early and seed stage investments, focusing on disruptive technology and tech transfer opportunities across various sectors, including healthcare, technology, nanotechnology, cleantech, advanced materials, and robotics. Cottonwood primarily invests in the Southwestern USA, with a particular emphasis on the region bordered by Phoenix, Denver, and Austin, including the Paso Del Norte region. The firm also invests in Northern Europe, specifically the Netherlands. Cottonwood typically invests between $1 million and $3 million per round, seeking a board seat in its portfolio companies.

David Blivin

Founder and Managing Partner

Dave Blivin

Managing Partner

Daan Boekhoudt

Investment Analyst

Patrick Claessen

Partner

Shinjan Dasgupta

Senior Analyst

Alain Loux

General Partner

Matthew Ongaro

Partner

Lee Rand

Partner

69 past transactions

Sencure

Series B in 2025
Sencure is a Dutch start-up established in 2021 that specializes in the development of integrated circuit technology for next-generation healthcare wearable devices. By uniting medical device developers and integrated circuit designers, Sencure focuses on creating ultra-low-power biometric sensing chips capable of measuring electrophysiological parameters on the human body. These innovations facilitate a variety of wearable biometric services, enabling healthcare professionals to monitor stress, activity levels, and other vital health metrics in real-time. Sencure's technology is applicable across diverse sectors, including health monitoring devices, disposable medical patches, and health tracking solutions, making it a significant player in the wearable biosensor technology market for remote health monitoring, preventative care, clinical research, and overall wellness.

Keiron

Seed Round in 2025
Keiron provides fully digital, contactless printing technology that replaces traditional stencil and jet printing technologies.

Green Theme Technologies

Series C in 2024
Green Theme Technologies Inc is a developer of environmentally-friendly chemical technology focused on the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company aims to innovate in the textile industry by creating products that surpass the performance of existing technologies while also eliminating water usage and reducing pollution. Green Theme Technologies is committed to sustainable practices and seeks to transform textile finishing processes through its advanced, dry technology solutions.

Q*BIRD

Seed Round in 2024
Q*Bird is a technology company focused on developing quantum networking solutions to support the current and future European quantum internet. It specializes in creating devices and infrastructure for quantum-secured data communications, including networking equipment that facilitates secure data transfer impervious to even the most advanced computing threats. The company’s product offerings include gadgets designed for the transmission of qubits and hubs that generate entanglement, enabling multipoint-to-multipoint connectivity. By providing innovative solutions such as quantum key distribution technology, Q*Bird aims to enhance security, promote cost-effective scaling, and improve the overall capabilities of digital infrastructure within the quantum networking space.

Circular Genomics

Series A in 2024
Circular Genomics, established in 2021 with headquarters in Albuquerque, New Mexico, specializes in pioneering precision medicine using circular RNA as novel biomarkers. The company focuses on improving the diagnosis and treatment of neurological and psychiatric conditions by developing RNA-based diagnostic assays, notably for depressive disorders. Their innovative approach enables evidence-based treatments, reducing time to therapeutic response and enhancing physicians' ability to manage psychiatric and neurological diseases effectively.

Infinitum

Series E in 2023
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

Orange Quantum Systems

Pre Seed Round in 2023
Orange Quantum Systems specializes in quantum software and services, focusing on the development of customized full-stack quantum systems. The company offers test equipment for quantum computing, including characterization systems for transmon qubits, which are essential for the advancement of quantum devices. In addition to providing maintenance and training, Orange Quantum Systems delivers tailored solutions to support clients in building their quantum computing projects and transitioning to industry-grade device development.

BioFlyte

Series B in 2023
BioFlyte is a company focused on developing advanced bio-threat detection devices aimed at enhancing safety and security against biological and low-volatility chemical threats. Their innovative instruments utilize a new class of fieldable aerosol mass spectrometers, equipped with state-of-the-art biodefense technologies. These devices are capable of identifying a wide range of airborne threats, including microbes, spores, vegetative bacteria, viruses, biotoxins, and opioids. By employing an efficient aerosol sample collector, BioFlyte's systems can analyze air, liquid, and powder samples, providing timely alerts to clients regarding potential bio-chemical dangers. This technology enables effective countermeasures against various threats, reinforcing the importance of safety in diverse environments.

Sencure

Series A in 2023
Sencure is a Dutch start-up established in 2021 that specializes in the development of integrated circuit technology for next-generation healthcare wearable devices. By uniting medical device developers and integrated circuit designers, Sencure focuses on creating ultra-low-power biometric sensing chips capable of measuring electrophysiological parameters on the human body. These innovations facilitate a variety of wearable biometric services, enabling healthcare professionals to monitor stress, activity levels, and other vital health metrics in real-time. Sencure's technology is applicable across diverse sectors, including health monitoring devices, disposable medical patches, and health tracking solutions, making it a significant player in the wearable biosensor technology market for remote health monitoring, preventative care, clinical research, and overall wellness.

Reyedar

Venture Round in 2023
Reyedar is a medical device manufacturer focused on enhancing the early detection of visual impairments and neurodegenerative disorders. The company develops non-invasive functional vision examinations that cater to opticians, optometrists, ophthalmologists, and researchers. By integrating eye tracking technology with artificial intelligence, Reyedar aims to streamline the diagnostic process for conditions such as glaucoma, reducing both operational costs and testing times in healthcare settings. Their innovative solutions facilitate efficient first-line eye health screenings, promoting better patient outcomes and supporting healthcare professionals in delivering timely diagnoses.

Team Wildfire

Seed Round in 2023
Team Wildfire is a company dedicated to developing innovative technologies aimed at wildfire suppression and environmental protection. It manufactures specialized jet engine sprays designed to effectively suppress fires, capture embers, and defend structures while also hardening evacuation routes. The company's advanced engineering and tactics address various environmental challenges, including wildfire mitigation, reforestation, dust control, oil spill cleanup, and protection against nuclear and biological threats. Through its cutting-edge solutions, Team Wildfire enables organizations to safeguard people, property, and the environment.

Infinitum

Series D in 2022
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

Green Theme Technologies

Series B in 2022
Green Theme Technologies Inc is a developer of environmentally-friendly chemical technology focused on the finishing of textiles and nonwovens. Founded in 2012 and based in Rio Rancho, New Mexico, the company aims to innovate in the textile industry by creating products that surpass the performance of existing technologies while also eliminating water usage and reducing pollution. Green Theme Technologies is committed to sustainable practices and seeks to transform textile finishing processes through its advanced, dry technology solutions.

Infinitum

Series D in 2022
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

BioFlyte

Series A in 2022
BioFlyte is a company focused on developing advanced bio-threat detection devices aimed at enhancing safety and security against biological and low-volatility chemical threats. Their innovative instruments utilize a new class of fieldable aerosol mass spectrometers, equipped with state-of-the-art biodefense technologies. These devices are capable of identifying a wide range of airborne threats, including microbes, spores, vegetative bacteria, viruses, biotoxins, and opioids. By employing an efficient aerosol sample collector, BioFlyte's systems can analyze air, liquid, and powder samples, providing timely alerts to clients regarding potential bio-chemical dangers. This technology enables effective countermeasures against various threats, reinforcing the importance of safety in diverse environments.

SmartNanotubes

Series A in 2022
SmartNanotubes Technologies is a start-up focused on developing advanced odor detection systems utilizing nanotechnology. The company specializes in creating smell detector chips that can identify gas odors and volatile organic compounds. These chips are designed for custom detector development and facilitate the characterization of gas mixtures, offering comprehensive solutions for businesses seeking to monitor and improve their production environments. By providing effective sensing technology, SmartNanotubes enables companies to ensure the quality of their products and enhance process control.

mPower Technology

Series B in 2022
mPower Technology, Inc. is a manufacturer of interconnected meshes of miniature solar cells, founded in 2014 and based in Albuquerque, New Mexico. The company specializes in developing semiconductor active miniature solar cells that cater to the space, terrestrial, and Internet of Things (IoT) industries. By utilizing advanced materials, processes, and tools from the silicon photovoltaic and microelectronics sectors, mPower Technology creates flexible solar solutions that overcome the limitations of traditional silicon and gallium arsenide solar cells. This innovative approach enables clients to optimize the performance and longevity of solar cells, particularly in challenging environments such as space, where they can recover from on-orbit radiation exposure. With a team of seasoned technology innovators and industry veterans, mPower Technology aims to advance the future of solar power globally.

Circular Genomics

Seed Round in 2021
Circular Genomics, established in 2021 with headquarters in Albuquerque, New Mexico, specializes in pioneering precision medicine using circular RNA as novel biomarkers. The company focuses on improving the diagnosis and treatment of neurological and psychiatric conditions by developing RNA-based diagnostic assays, notably for depressive disorders. Their innovative approach enables evidence-based treatments, reducing time to therapeutic response and enhancing physicians' ability to manage psychiatric and neurological diseases effectively.

Armonica Technologies

Series B in 2021
Armonica Technologies is an early-stage medtech company that specializes in developing innovative long-read DNA sequencing technology aimed at precision medicine applications. Named after Benjamin Franklin’s Glass Armonica, the company focuses on a proprietary platform capable of sequencing a complete human genome in minutes. This advanced technology utilizes nanochannels to transport single nucleic acid molecules through nanopores, which are then analyzed through optical readout via Raman spectroscopy. By addressing the limitations of existing sequencing methods, Armonica Technologies enables life science researchers and clinicians to gain a comprehensive view of the genome, providing critical insights into epigenetic modifications. The company's approach is supported by a portfolio of patented and patent-pending technologies licensed from STC.UNM.

Infinitum

Series C in 2021
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

Sencure

Seed Round in 2021
Sencure is a Dutch start-up established in 2021 that specializes in the development of integrated circuit technology for next-generation healthcare wearable devices. By uniting medical device developers and integrated circuit designers, Sencure focuses on creating ultra-low-power biometric sensing chips capable of measuring electrophysiological parameters on the human body. These innovations facilitate a variety of wearable biometric services, enabling healthcare professionals to monitor stress, activity levels, and other vital health metrics in real-time. Sencure's technology is applicable across diverse sectors, including health monitoring devices, disposable medical patches, and health tracking solutions, making it a significant player in the wearable biosensor technology market for remote health monitoring, preventative care, clinical research, and overall wellness.

BayoTech

Series C in 2021
BayoTech, Inc. is a company specializing in the development and manufacture of hydrogen generation systems, including steam methane reformers. Founded in 2015 and based in Albuquerque, New Mexico, BayoTech focuses on advancing hydrogen innovation and sustainability by providing low-carbon hydrogen solutions aimed at reducing transportation emissions and optimizing the supply chain through local production. The company operates a network of hydrogen production hubs, known as BayoGaaS® Hydrogen Hubs, with sites in Wentzville, Missouri, and an upcoming facility in Stockton, California. Additionally, BayoTech manufactures high-capacity, high-pressure transport trailers in Tulsa, Oklahoma, to ensure safe and reliable distribution of hydrogen. The company's comprehensive portfolio includes solutions for hydrogen production, transport, storage, and fueling, making low-carbon hydrogen accessible and cost-effective for various sectors, including agriculture, fuel cells, and energy.

BennuBio

Series B in 2020
BennuBio, Inc. is a technology company based in Albuquerque, New Mexico, that specializes in developing advanced flow cytometry equipment for cell analysis. Founded in 2018, BennuBio focuses on creating instruments capable of sorting and analyzing cells for rare cell applications, which include monitoring blood cells, detecting biomarkers, and facilitating drug discovery. Its flagship product, The Velocyt, enables users to detect rare events such as activated T cells and circulating tumor cells, making it valuable for personalized medicine. The company also offers spheroid generation systems and high-volume sorting systems, along with technical support and applications assistance. By allowing analysis across a wide range of particle sizes and sample volumes, BennuBio aims to enhance the capabilities of healthcare professionals in immuno-oncology treatment and diagnostics.

mPower Technology

Series A in 2020
mPower Technology, Inc. is a manufacturer of interconnected meshes of miniature solar cells, founded in 2014 and based in Albuquerque, New Mexico. The company specializes in developing semiconductor active miniature solar cells that cater to the space, terrestrial, and Internet of Things (IoT) industries. By utilizing advanced materials, processes, and tools from the silicon photovoltaic and microelectronics sectors, mPower Technology creates flexible solar solutions that overcome the limitations of traditional silicon and gallium arsenide solar cells. This innovative approach enables clients to optimize the performance and longevity of solar cells, particularly in challenging environments such as space, where they can recover from on-orbit radiation exposure. With a team of seasoned technology innovators and industry veterans, mPower Technology aims to advance the future of solar power globally.

Infinitum

Series B in 2019
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

OPNT

Convertible Note in 2019
OPNT is a Dutch technology company spun off from LaserLaB at VU University Amsterdam. It specializes in providing accurate time distribution and frequency division systems for businesses, particularly those reliant on telecommunications networks. OPNT's core offering is a GPS-based service that leverages existing fiber-optic infrastructure to synchronize clocks independently of GPS timing, reducing operational expenses (OPEX) while maintaining the reliability of standard telecom equipment.

Infinitum

Series A in 2019
Infinitum is a pioneering company focused on advancing motor technology with a commitment to sustainability and efficiency. It specializes in developing lightweight electric motors that utilize printed circuit board stator technology, which significantly enhances motor performance while reducing costs. By replacing traditional iron and copper components, Infinitum's motors are designed to be smaller, lighter, and quieter than conventional alternatives, thereby providing exceptional energy savings and a reduced carbon footprint throughout their lifecycle. The company's innovative approach not only opens up new sustainable design possibilities for end users but also aims to make a meaningful impact on environmental conservation and energy efficiency.

Palladyne AI

Series B in 2018
Palladyne AI is a software company specializing in advanced robotic technology that enhances the intelligence and efficiency of robotic systems. By leveraging artificial intelligence and machine learning, Palladyne AI's platform enables robots to observe, learn, reason, and act in ways that closely resemble human intelligence. This innovative software empowers robots to autonomously adapt to dynamic environments, allowing them to perceive and respond to changes in real-time. The applications of Palladyne AI's technology span various industries, including automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics, and warehousing, positioning the company as a key player in the evolution of robotics.

BennuBio

Series A in 2018
BennuBio, Inc. is a technology company based in Albuquerque, New Mexico, that specializes in developing advanced flow cytometry equipment for cell analysis. Founded in 2018, BennuBio focuses on creating instruments capable of sorting and analyzing cells for rare cell applications, which include monitoring blood cells, detecting biomarkers, and facilitating drug discovery. Its flagship product, The Velocyt, enables users to detect rare events such as activated T cells and circulating tumor cells, making it valuable for personalized medicine. The company also offers spheroid generation systems and high-volume sorting systems, along with technical support and applications assistance. By allowing analysis across a wide range of particle sizes and sample volumes, BennuBio aims to enhance the capabilities of healthcare professionals in immuno-oncology treatment and diagnostics.

Eurekite

Series A in 2018
Eurekite BV, based in Enschede, the Netherlands, specializes in the manufacture of flexible ceramic materials. Established in May 2015 as a spin-off from the University of Twente, the company focuses on the development and commercialization of its innovative technology, known as Flexiramics®. This technology emerged from the Inorganic Materials Science Group of the MESA + Institute for Nanotechnology, led by Professor Andre ten Elshof. Eurekite combines expertise in formulation chemistry, production technology, and composite development, with its disruptive materials attracting investment from prominent venture capital firms.

BayoTech

Series B in 2018
BayoTech, Inc. is a company specializing in the development and manufacture of hydrogen generation systems, including steam methane reformers. Founded in 2015 and based in Albuquerque, New Mexico, BayoTech focuses on advancing hydrogen innovation and sustainability by providing low-carbon hydrogen solutions aimed at reducing transportation emissions and optimizing the supply chain through local production. The company operates a network of hydrogen production hubs, known as BayoGaaS® Hydrogen Hubs, with sites in Wentzville, Missouri, and an upcoming facility in Stockton, California. Additionally, BayoTech manufactures high-capacity, high-pressure transport trailers in Tulsa, Oklahoma, to ensure safe and reliable distribution of hydrogen. The company's comprehensive portfolio includes solutions for hydrogen production, transport, storage, and fueling, making low-carbon hydrogen accessible and cost-effective for various sectors, including agriculture, fuel cells, and energy.

RoBird

Series B in 2017
Clear Flight Solutions is a Dutch company combining expert knowledge of unmanned aerial vehicles with extensive expertise in the ecological domain. Whether the situation requires a robotic bird of prey or a stable multicopter, the Company provides a working solution. With the Robirds, flying on unique patented flapping wing technology, the Company offers unmatched effectiveness in the field of bird control. Clear Flight Solutions also offers unique platforms for wildlife observation and protection, safety and surveillance, and surveying and mapping. After winning the UVS International Innovation Award in 2011, the Company was founded in 2012 as a spin-off of the University of Twente. Clear Flight Solutions has obtained a $1.7 million investment from the Cottonwood Euro Technology Fund early 2015. The Company was elected Startup of the Year in the Twente region in 2015 and has recently been awarded with the euRobotics Technology Transfer Award, the ASME Young Technology Award, as well as the first ever EU Drone Award for best drone-based solution.

SoundEnergy

Venture Round in 2017
Sound Energy BV is focused on developing and commercializing innovative technologies aimed at reducing fossil energy consumption. The company specializes in Thermo Acoustic Technology, which provides a sustainable solution for climate control in buildings. By utilizing hot water for cooling, Sound Energy's heat engines and heat pumps eliminate the need for electricity or gas, allowing homeowners to manage energy consumption while achieving zero carbon dioxide emissions. With a commitment to sustainability, the company integrates environmental considerations with scientific expertise and a pragmatic business approach, ensuring that its technologies serve both ecological and economic interests.

Armonica Technologies

Seed Round in 2017
Armonica Technologies is an early-stage medtech company that specializes in developing innovative long-read DNA sequencing technology aimed at precision medicine applications. Named after Benjamin Franklin’s Glass Armonica, the company focuses on a proprietary platform capable of sequencing a complete human genome in minutes. This advanced technology utilizes nanochannels to transport single nucleic acid molecules through nanopores, which are then analyzed through optical readout via Raman spectroscopy. By addressing the limitations of existing sequencing methods, Armonica Technologies enables life science researchers and clinicians to gain a comprehensive view of the genome, providing critical insights into epigenetic modifications. The company's approach is supported by a portfolio of patented and patent-pending technologies licensed from STC.UNM.

OPNT

Convertible Note in 2017
OPNT is a Dutch technology company spun off from LaserLaB at VU University Amsterdam. It specializes in providing accurate time distribution and frequency division systems for businesses, particularly those reliant on telecommunications networks. OPNT's core offering is a GPS-based service that leverages existing fiber-optic infrastructure to synchronize clocks independently of GPS timing, reducing operational expenses (OPEX) while maintaining the reliability of standard telecom equipment.

TriLumina

Venture Round in 2017
TriLumina Corporation, founded in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly advanced vertical-cavity surface-emitting lasers (VCSEL). The company provides cutting-edge illumination solutions for 3D sensing and LiDAR applications across various industries, including automotive, industrial, and mobile sectors. TriLumina's patented VCSEL technology supports the development of innovative applications such as augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Its products are designed for use in sophisticated systems like Time-of-Flight and Long Range LiDAR, achieving notable qualifications such as automotive Grade 1 temperature range certification. This positions TriLumina as a preferred platform in the realm of 3D sensing technologies, enabling clients to enhance operational efficiency and drive technological advancements.

Palladyne AI

Venture Round in 2016
Palladyne AI is a software company specializing in advanced robotic technology that enhances the intelligence and efficiency of robotic systems. By leveraging artificial intelligence and machine learning, Palladyne AI's platform enables robots to observe, learn, reason, and act in ways that closely resemble human intelligence. This innovative software empowers robots to autonomously adapt to dynamic environments, allowing them to perceive and respond to changes in real-time. The applications of Palladyne AI's technology span various industries, including automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics, and warehousing, positioning the company as a key player in the evolution of robotics.

OPNT

Series A in 2015
OPNT is a Dutch technology company spun off from LaserLaB at VU University Amsterdam. It specializes in providing accurate time distribution and frequency division systems for businesses, particularly those reliant on telecommunications networks. OPNT's core offering is a GPS-based service that leverages existing fiber-optic infrastructure to synchronize clocks independently of GPS timing, reducing operational expenses (OPEX) while maintaining the reliability of standard telecom equipment.

Eurekite

Seed Round in 2015
Eurekite BV, based in Enschede, the Netherlands, specializes in the manufacture of flexible ceramic materials. Established in May 2015 as a spin-off from the University of Twente, the company focuses on the development and commercialization of its innovative technology, known as Flexiramics®. This technology emerged from the Inorganic Materials Science Group of the MESA + Institute for Nanotechnology, led by Professor Andre ten Elshof. Eurekite combines expertise in formulation chemistry, production technology, and composite development, with its disruptive materials attracting investment from prominent venture capital firms.

RoBird

Series A in 2015
Clear Flight Solutions is a Dutch company combining expert knowledge of unmanned aerial vehicles with extensive expertise in the ecological domain. Whether the situation requires a robotic bird of prey or a stable multicopter, the Company provides a working solution. With the Robirds, flying on unique patented flapping wing technology, the Company offers unmatched effectiveness in the field of bird control. Clear Flight Solutions also offers unique platforms for wildlife observation and protection, safety and surveillance, and surveying and mapping. After winning the UVS International Innovation Award in 2011, the Company was founded in 2012 as a spin-off of the University of Twente. Clear Flight Solutions has obtained a $1.7 million investment from the Cottonwood Euro Technology Fund early 2015. The Company was elected Startup of the Year in the Twente region in 2015 and has recently been awarded with the euRobotics Technology Transfer Award, the ASME Young Technology Award, as well as the first ever EU Drone Award for best drone-based solution.

Masterson Industries

Series A in 2015
Masterson Industries, LLC is a manufacturer specializing in microgravity-enabled and semiconductor materials, notably gallium nitride. Founded in 2012 and headquartered in Albuquerque, New Mexico, the company focuses on the development and production of specialty materials that serve a diverse range of industries, including defense, medical devices, electronics, and telecommunications. Masterson Industries has established a significant portfolio of intellectual property and recently expanded its operations by moving into a new production facility. The company has also enhanced its team with sales and marketing expertise tailored to each targeted industry, positioning itself for commercial expansion. Currently, it is preparing for a commercialization demonstration to showcase its innovative capabilities.

Skorpios Technologies

Series D in 2015
Skorpios Technologies, Inc. is a fabless semiconductor company based in Albuquerque, New Mexico, specializing in silicon photonic integrated circuit products. Founded in 2009, the company develops and markets a range of opto-electronic integrated circuits, including 100G-CWDM system-on-chip receivers and transmitters. Skorpios Technologies also offers innovative solutions such as Template Assisted Bonding, which supports high-speed video, data, and voice communications across networking, cloud computing, storage, and cable TV applications. Additionally, the company provides gain materials, wafer-scale processes, uncooled tunable laser technology, and coherent transceiver devices. By designing and manufacturing integrated optical modules and subsystems, Skorpios enables high-bandwidth interconnectivity at competitive manufacturing costs, serving various sectors including aerospace and defense, bioelectronics, and communications.

TriLumina

Series B in 2015
TriLumina Corporation, founded in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly advanced vertical-cavity surface-emitting lasers (VCSEL). The company provides cutting-edge illumination solutions for 3D sensing and LiDAR applications across various industries, including automotive, industrial, and mobile sectors. TriLumina's patented VCSEL technology supports the development of innovative applications such as augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Its products are designed for use in sophisticated systems like Time-of-Flight and Long Range LiDAR, achieving notable qualifications such as automotive Grade 1 temperature range certification. This positions TriLumina as a preferred platform in the realm of 3D sensing technologies, enabling clients to enhance operational efficiency and drive technological advancements.

Raptor Products

Series A in 2015
Raptor Products Inc., established in [year], specializes in manufacturing firearms accessories designed for secure storage, display, and easy accessibility. Their product line focuses on highly durable mounting systems crafted from polymer and stainless steel, utilizing auto-locking technology that securely attaches to the Picatinny rail of firearms. This innovative design caters primarily to military personnel, law enforcement officers, shooting enthusiasts, and gun store owners, offering a versatile solution for home defense, tactical teams, and secure firearm display.

Respira Therapeutics

Convertible Note in 2015
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, that specializes in the pulmonary delivery of therapeutics for respiratory diseases. Founded in 2010, the company is focused on addressing unmet medical needs through its innovative technology for passive dry powder inhalers (DPIs). Respira's proprietary drug delivery engine features a novel mechanism of action that enhances lung delivery and therapy. The company has achieved clinical proof-of-principle, demonstrating that its DPIs offer best-in-class drug dispersion performance. This positions Respira to potentially replace existing inhalation devices and expand inhaled therapies across various drug classes and disease indications, targeting high-value therapeutic areas. Respira Therapeutics has also entered into a strategic collaboration with United Therapeutics Corporation to further its development efforts.

Respira Therapeutics

Convertible Note in 2014
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, that specializes in the pulmonary delivery of therapeutics for respiratory diseases. Founded in 2010, the company is focused on addressing unmet medical needs through its innovative technology for passive dry powder inhalers (DPIs). Respira's proprietary drug delivery engine features a novel mechanism of action that enhances lung delivery and therapy. The company has achieved clinical proof-of-principle, demonstrating that its DPIs offer best-in-class drug dispersion performance. This positions Respira to potentially replace existing inhalation devices and expand inhaled therapies across various drug classes and disease indications, targeting high-value therapeutic areas. Respira Therapeutics has also entered into a strategic collaboration with United Therapeutics Corporation to further its development efforts.

Exagen

Debt Financing in 2014
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

xF Technologies

Debt Financing in 2014
xF Technologies Inc. is a specialty chemicals manufacturer based in Albuquerque, New Mexico, founded in 2007. The company focuses on converting renewable biomass materials, such as cornstarch, sugarcane, and cellulosic biomass, into non-toxic renewable chemicals and biofuels. Its product offerings include various chemical compounds, such as methyl, ethyl, and isopropyl derivatives, along with plasticizers for the PVC market, cleaning solvents, and agricultural chemicals. xF Technologies employs a patented molecular platform to produce furaotes, which are designed to replace traditional petrochemical ingredients while providing similar or superior performance. This innovation allows for significant cost savings in formulations and enhances the environmental health and safety profile of the final products. The company aims to contribute to sustainability by recycling renewable waste biomass into valuable chemical products.

TriLumina

Series A in 2014
TriLumina Corporation, founded in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly advanced vertical-cavity surface-emitting lasers (VCSEL). The company provides cutting-edge illumination solutions for 3D sensing and LiDAR applications across various industries, including automotive, industrial, and mobile sectors. TriLumina's patented VCSEL technology supports the development of innovative applications such as augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Its products are designed for use in sophisticated systems like Time-of-Flight and Long Range LiDAR, achieving notable qualifications such as automotive Grade 1 temperature range certification. This positions TriLumina as a preferred platform in the realm of 3D sensing technologies, enabling clients to enhance operational efficiency and drive technological advancements.

xF Technologies

Series A in 2014
xF Technologies Inc. is a specialty chemicals manufacturer based in Albuquerque, New Mexico, founded in 2007. The company focuses on converting renewable biomass materials, such as cornstarch, sugarcane, and cellulosic biomass, into non-toxic renewable chemicals and biofuels. Its product offerings include various chemical compounds, such as methyl, ethyl, and isopropyl derivatives, along with plasticizers for the PVC market, cleaning solvents, and agricultural chemicals. xF Technologies employs a patented molecular platform to produce furaotes, which are designed to replace traditional petrochemical ingredients while providing similar or superior performance. This innovation allows for significant cost savings in formulations and enhances the environmental health and safety profile of the final products. The company aims to contribute to sustainability by recycling renewable waste biomass into valuable chemical products.

Skorpios Technologies

Series C in 2013
Skorpios Technologies, Inc. is a fabless semiconductor company based in Albuquerque, New Mexico, specializing in silicon photonic integrated circuit products. Founded in 2009, the company develops and markets a range of opto-electronic integrated circuits, including 100G-CWDM system-on-chip receivers and transmitters. Skorpios Technologies also offers innovative solutions such as Template Assisted Bonding, which supports high-speed video, data, and voice communications across networking, cloud computing, storage, and cable TV applications. Additionally, the company provides gain materials, wafer-scale processes, uncooled tunable laser technology, and coherent transceiver devices. By designing and manufacturing integrated optical modules and subsystems, Skorpios enables high-bandwidth interconnectivity at competitive manufacturing costs, serving various sectors including aerospace and defense, bioelectronics, and communications.

Exagen

Debt Financing in 2013
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

Masterson Industries

Series A in 2013
Masterson Industries, LLC is a manufacturer specializing in microgravity-enabled and semiconductor materials, notably gallium nitride. Founded in 2012 and headquartered in Albuquerque, New Mexico, the company focuses on the development and production of specialty materials that serve a diverse range of industries, including defense, medical devices, electronics, and telecommunications. Masterson Industries has established a significant portfolio of intellectual property and recently expanded its operations by moving into a new production facility. The company has also enhanced its team with sales and marketing expertise tailored to each targeted industry, positioning itself for commercial expansion. Currently, it is preparing for a commercialization demonstration to showcase its innovative capabilities.

Respira Therapeutics

Series A in 2013
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, that specializes in the pulmonary delivery of therapeutics for respiratory diseases. Founded in 2010, the company is focused on addressing unmet medical needs through its innovative technology for passive dry powder inhalers (DPIs). Respira's proprietary drug delivery engine features a novel mechanism of action that enhances lung delivery and therapy. The company has achieved clinical proof-of-principle, demonstrating that its DPIs offer best-in-class drug dispersion performance. This positions Respira to potentially replace existing inhalation devices and expand inhaled therapies across various drug classes and disease indications, targeting high-value therapeutic areas. Respira Therapeutics has also entered into a strategic collaboration with United Therapeutics Corporation to further its development efforts.

xF Technologies

Series A in 2013
xF Technologies Inc. is a specialty chemicals manufacturer based in Albuquerque, New Mexico, founded in 2007. The company focuses on converting renewable biomass materials, such as cornstarch, sugarcane, and cellulosic biomass, into non-toxic renewable chemicals and biofuels. Its product offerings include various chemical compounds, such as methyl, ethyl, and isopropyl derivatives, along with plasticizers for the PVC market, cleaning solvents, and agricultural chemicals. xF Technologies employs a patented molecular platform to produce furaotes, which are designed to replace traditional petrochemical ingredients while providing similar or superior performance. This innovation allows for significant cost savings in formulations and enhances the environmental health and safety profile of the final products. The company aims to contribute to sustainability by recycling renewable waste biomass into valuable chemical products.

VeriTran

Seed Round in 2013
VeriTran Inc. is a company based in Albuquerque, New Mexico, specializing in the development of infinitely variable transmissions and powertrains. Founded in 1998 by the inventors of its patented technology, the company designs compact belted drives that cater to adjustable and variable speed applications for electric motors. Its products find utility across a range of sectors, including electric motor variable speed drives, engine-driven generators, small wind turbines, and automotive transmissions. VeriTran also engages in strategic partnerships to enhance its technological offerings and expand its market reach.

FibeRio Technology

Series C in 2013
FibeRio Technology Corporation specializes in the development of nanofiber production systems, offering innovative technology that enables manufacturers to produce nanofibers at a commercial scale. The company employs an environmentally sensitive process that utilizes polymers, ensuring both quality and efficiency. FibeRio is committed to meeting the growing market demands for nanofibers by providing advanced equipment and processes. Through its Forcespinning technology, the company is rapidly advancing its manufacturing capabilities, delivering high-quality and cost-effective solutions to its customers.

TriLumina

Series A in 2013
TriLumina Corporation, founded in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly advanced vertical-cavity surface-emitting lasers (VCSEL). The company provides cutting-edge illumination solutions for 3D sensing and LiDAR applications across various industries, including automotive, industrial, and mobile sectors. TriLumina's patented VCSEL technology supports the development of innovative applications such as augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Its products are designed for use in sophisticated systems like Time-of-Flight and Long Range LiDAR, achieving notable qualifications such as automotive Grade 1 temperature range certification. This positions TriLumina as a preferred platform in the realm of 3D sensing technologies, enabling clients to enhance operational efficiency and drive technological advancements.

Exagen

Series C in 2012
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

xF Technologies

Series A in 2012
xF Technologies Inc. is a specialty chemicals manufacturer based in Albuquerque, New Mexico, founded in 2007. The company focuses on converting renewable biomass materials, such as cornstarch, sugarcane, and cellulosic biomass, into non-toxic renewable chemicals and biofuels. Its product offerings include various chemical compounds, such as methyl, ethyl, and isopropyl derivatives, along with plasticizers for the PVC market, cleaning solvents, and agricultural chemicals. xF Technologies employs a patented molecular platform to produce furaotes, which are designed to replace traditional petrochemical ingredients while providing similar or superior performance. This innovation allows for significant cost savings in formulations and enhances the environmental health and safety profile of the final products. The company aims to contribute to sustainability by recycling renewable waste biomass into valuable chemical products.

InView

Series A in 2012
InView Technology Corporation, established in 2009 and headquartered in Austin, Texas, specializes in the development and manufacturing of compressive sensing-based imaging and hyperspectral imaging products. The company's offerings include CompressView software for data management, shortwave infrared (SWIR) cameras, and controllable spatial light modulator systems. Its applications span microscopy and life sciences, military and surveillance, maritime, industrial process control, food and pharmaceutical inspection, energy audits, material research, and security. InView's technology enables low-cost, high-performance imaging solutions, making it accessible for a wide range of commercial and laboratory applications.

Exagen

Venture Round in 2012
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

Exagen

Venture Round in 2011
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

Skorpios Technologies

Series B in 2011
Skorpios Technologies, Inc. is a fabless semiconductor company based in Albuquerque, New Mexico, specializing in silicon photonic integrated circuit products. Founded in 2009, the company develops and markets a range of opto-electronic integrated circuits, including 100G-CWDM system-on-chip receivers and transmitters. Skorpios Technologies also offers innovative solutions such as Template Assisted Bonding, which supports high-speed video, data, and voice communications across networking, cloud computing, storage, and cable TV applications. Additionally, the company provides gain materials, wafer-scale processes, uncooled tunable laser technology, and coherent transceiver devices. By designing and manufacturing integrated optical modules and subsystems, Skorpios enables high-bandwidth interconnectivity at competitive manufacturing costs, serving various sectors including aerospace and defense, bioelectronics, and communications.

FibeRio Technology

Series B in 2011
FibeRio Technology Corporation specializes in the development of nanofiber production systems, offering innovative technology that enables manufacturers to produce nanofibers at a commercial scale. The company employs an environmentally sensitive process that utilizes polymers, ensuring both quality and efficiency. FibeRio is committed to meeting the growing market demands for nanofibers by providing advanced equipment and processes. Through its Forcespinning technology, the company is rapidly advancing its manufacturing capabilities, delivering high-quality and cost-effective solutions to its customers.

Exagen

Venture Round in 2011
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

Exagen

Venture Round in 2011
Exagen Inc. is a commercial-stage diagnostics company focused on developing and commercializing innovative testing products for autoimmune and autoimmune-related diseases. Headquartered in Vista, California, Exagen utilizes its proprietary Cell-Bound Complement Activation Products technology to enhance diagnostic care for conditions like systemic lupus erythematosus and rheumatoid arthritis. The company offers a diverse portfolio of testing products under its AVISE brand, including AVISE CTD for differential diagnosis of connective tissue diseases, AVISE Lupus for monitoring complement system activation, and multiple panels for assessing various autoimmune markers. These products facilitate timely diagnosis and effective therapeutic interventions, enabling rheumatologists to improve patient care. Since its founding in 2002, Exagen has remained committed to addressing the needs of patients suffering from chronic autoimmune diseases.

Respira Therapeutics

Series A in 2010
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, that specializes in the pulmonary delivery of therapeutics for respiratory diseases. Founded in 2010, the company is focused on addressing unmet medical needs through its innovative technology for passive dry powder inhalers (DPIs). Respira's proprietary drug delivery engine features a novel mechanism of action that enhances lung delivery and therapy. The company has achieved clinical proof-of-principle, demonstrating that its DPIs offer best-in-class drug dispersion performance. This positions Respira to potentially replace existing inhalation devices and expand inhaled therapies across various drug classes and disease indications, targeting high-value therapeutic areas. Respira Therapeutics has also entered into a strategic collaboration with United Therapeutics Corporation to further its development efforts.

FibeRio Technology

Series A in 2010
FibeRio Technology Corporation specializes in the development of nanofiber production systems, offering innovative technology that enables manufacturers to produce nanofibers at a commercial scale. The company employs an environmentally sensitive process that utilizes polymers, ensuring both quality and efficiency. FibeRio is committed to meeting the growing market demands for nanofibers by providing advanced equipment and processes. Through its Forcespinning technology, the company is rapidly advancing its manufacturing capabilities, delivering high-quality and cost-effective solutions to its customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.